QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins
UnitedHealth expects Medicaid margins to bottom in 2026 and improve through 2028, UnitedHealthcare CEO Tim Noel says on earnings call.
Stocks · News reference
DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test
Humana includes DataMeds AI's Helomics ChemoFx assay in its Medicaid policy for gynecologic cancers, expanding payer reimbursement.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Humana To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Analysts cut targets for Duke, Hyatt, Pershing Square, Carlisle, Upstart, Arch Capital and Meta; raised VF, Rexford and SentinelOne.
Mizuho Maintains Outperform on Humana, Raises Price Target to $495
Mizuho analyst Ann Hynes maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $468 to $495.
Humana Forms JV With BlackRock To Manage And Operate Existing Network Of CenterWell Senior Primary Care Clinics; Reaffirms FY26 Adjusted EPS Guidance
Humana Inc. (the "Company") issued a press release today reporting its entry into a new joint venture arrangement with funds and accounts managed by HPS Investment Partners, a subsidiary of BlackRock, Inc.
DataMeds AI Enters IP License Agreement With Reboot Health AI On Oct 13, 2026; Reboot Grants DataMeds AI Exclusive License To Patents And Health AI Platform In U.S.; Reboot To Receive Portion Of DataMeds AI's Adj Gross Revenue; Co To Issue Reboot 666,667 Shares As IP License Stock Component
On October 13, 2026 (the "Effective Date"), DataMeds AI, Inc. ("DataMeds" or the "Company") entered into an Intellectual Property License and Product and Services Agreement (the "IP License
8-K filing — DataMeds AI, Inc. (MEDS)
Filed: 2026-10-16 AccNo: 0001493152-26-047451 Size: 213 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 3.02: Unregistered Sales of Equity Securities